MPLT · Categories · Form 4

MPLT - SEC Form 4 insider transactions

MapLight Therapeutics Inc. (MPLT) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for MPLT

• 9d
  SEC Form 4 filed by Foff Erin Pennock

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Lillie James Woodruff

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Hanson Kristopher

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Gillis Jonathan

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Kreitzer Anatol

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Setia Vishwas

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Kroeger Christopher A.

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 9d
  SEC Form 4 filed by Malenka Robert C.

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 61d
  Director Malenka Robert C. sold $260,398 worth of Voting Common Stock (14,195 units at $18.34), decreasing direct ownership by 4% to 325,059 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 67d
  Director Malenka Robert C. sold $220,632 worth of Voting Common Stock (12,116 units at $18.21), decreasing direct ownership by 3% to 339,254 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 73d
  Director Malenka Robert C. sold $124,329 worth of Voting Common Stock (6,863 units at $18.12), decreasing direct ownership by 2% to 351,370 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  CAAO and PAO Gillis Jonathan was granted 6,020 units of Voting Common Stock, increasing direct ownership by 2% to 254,523 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  Chief Scientific Officer Lillie James Woodruff was granted 7,730 units of Voting Common Stock, increasing direct ownership by 3% to 298,862 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  Chief Financial Officer Setia Vishwas was granted 7,730 units of Voting Common Stock, increasing direct ownership by 2% to 395,549 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  Chief Discovery Officer Kreitzer Anatol was granted 6,020 units of Voting Common Stock, increasing direct ownership by 2% to 259,928 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  General Counsel Hanson Kristopher was granted 7,730 units of Voting Common Stock, increasing direct ownership by 4% to 191,582 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  Chief Executive Officer Kroeger Christopher A. was granted 23,145 units of Voting Common Stock, increasing direct ownership by 1% to 1,649,751 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 76d
  Chief Medical Officer Foff Erin Pennock was granted 13,360 units of Voting Common Stock, increasing direct ownership by 3% to 403,835 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 80d
  Director Malenka Robert C. sold $126,861 worth of Voting Common Stock (7,040 units at $18.02), decreasing direct ownership by 2% to 358,233 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 86d
  Director Malenka Robert C. sold $635,857 worth of Voting Common Stock (34,398 units at $18.49), decreasing direct ownership by 9% to 365,273 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  Chief Financial Officer Setia Vishwas covered exercise/tax liability with 33,382 units of Voting Common Stock, decreasing direct ownership by 8% to 387,819 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  CAAO and PAO Gillis Jonathan covered exercise/tax liability with 22,050 units of Voting Common Stock, decreasing direct ownership by 8% to 248,503 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  Chief Scientific Officer Lillie James Woodruff covered exercise/tax liability with 45,055 units of Voting Common Stock, decreasing direct ownership by 13% to 291,132 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  Chief Discovery Officer Kreitzer Anatol covered exercise/tax liability with 42,099 units of Voting Common Stock, decreasing direct ownership by 14% to 253,908 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  Chief Executive Officer Kroeger Christopher A. covered exercise/tax liability with 204,146 units of Voting Common Stock, decreasing direct ownership by 11% to 1,626,606 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  General Counsel Hanson Kristopher covered exercise/tax liability with 26,007 units of Voting Common Stock, decreasing direct ownership by 12% to 183,852 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)
• 87d
  Chief Medical Officer Foff Erin Pennock covered exercise/tax liability with 44,616 units of Voting Common Stock, decreasing direct ownership by 10% to 390,475 units (SEC Form 4)

  4 - MapLight Therapeutics, Inc. (0001770069) (Issuer)

Other MPLT categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends